Kenvue Inc. $KVUE Shares Acquired by Viking Fund Management LLC

Viking Fund Management LLC boosted its holdings in Kenvue Inc. (NYSE:KVUE) by 36.0% in the third quarter, HoldingsChannel.com reports. The firm owned 605,000 shares of the company’s stock after acquiring an additional 160,000 shares during the period. Kenvue accounts for approximately 1.2% of Viking Fund Management LLC’s investment portfolio, making the stock its 27th biggest holding. Viking Fund Management LLC’s holdings in Kenvue were worth $9,819,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the business. Renaissance Capital LLC lifted its holdings in Kenvue by 8.3% in the second quarter. Renaissance Capital LLC now owns 629,177 shares of the company’s stock worth $13,169,000 after acquiring an additional 48,267 shares during the last quarter. Farther Finance Advisors LLC grew its holdings in shares of Kenvue by 80.7% during the second quarter. Farther Finance Advisors LLC now owns 36,196 shares of the company’s stock valued at $758,000 after purchasing an additional 16,164 shares during the last quarter. Arlington Partners LLC bought a new stake in shares of Kenvue in the 2nd quarter worth approximately $2,110,000. AG2R LA Mondiale Gestion D Actifs acquired a new position in Kenvue during the 1st quarter valued at approximately $1,725,000. Finally, Cornell Pochily Investment Advisors Inc. grew its stake in Kenvue by 144.6% during the 2nd quarter. Cornell Pochily Investment Advisors Inc. now owns 33,173 shares of the company’s stock worth $694,000 after buying an additional 19,609 shares during the last quarter. Institutional investors own 97.64% of the company’s stock.

Insider Activity at Kenvue

In other Kenvue news, Director Jeffrey C. Smith bought 3,200,000 shares of the business’s stock in a transaction that occurred on Friday, December 12th. The stock was acquired at an average cost of $17.37 per share, with a total value of $55,584,000.00. Following the completion of the purchase, the director directly owned 27,307,632 shares in the company, valued at approximately $474,333,567.84. This trade represents a 13.27% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link. 1.68% of the stock is owned by insiders.

Analyst Ratings Changes

Several equities research analysts have weighed in on KVUE shares. Evercore ISI set a $18.00 target price on Kenvue in a research report on Tuesday, October 28th. Johnson Rice restated a “neutral” rating on shares of Kenvue in a research report on Tuesday, October 28th. UBS Group lowered their price target on Kenvue from $23.00 to $17.00 and set a “neutral” rating on the stock in a report on Wednesday, October 8th. Zacks Research raised shares of Kenvue from a “strong sell” rating to a “hold” rating in a report on Wednesday, November 26th. Finally, Barclays increased their target price on shares of Kenvue from $17.00 to $18.00 and gave the company an “equal weight” rating in a research report on Monday, November 10th. One analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and twelve have assigned a Hold rating to the stock. According to MarketBeat.com, Kenvue currently has a consensus rating of “Hold” and an average target price of $20.23.

Kenvue Stock Down 0.5%

KVUE opened at $17.02 on Friday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 0.98. The company has a market capitalization of $32.61 billion, a PE ratio of 22.69 and a beta of 0.60. The stock’s fifty day moving average is $16.29 and its 200-day moving average is $18.87. Kenvue Inc. has a one year low of $14.02 and a one year high of $25.17.

Kenvue (NYSE:KVUE) last announced its earnings results on Monday, November 3rd. The company reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.01. Kenvue had a return on equity of 20.02% and a net margin of 9.55%.The business had revenue of $3.76 billion during the quarter, compared to analysts’ expectations of $3.83 billion. During the same quarter last year, the business posted $0.28 earnings per share. The company’s quarterly revenue was down 3.5% on a year-over-year basis. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. On average, equities analysts predict that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, November 26th. Stockholders of record on Wednesday, November 12th were paid a $0.2075 dividend. The ex-dividend date of this dividend was Wednesday, November 12th. This represents a $0.83 annualized dividend and a dividend yield of 4.9%. Kenvue’s payout ratio is currently 110.67%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.